Journals / Türk Oftalmoloji Dergisi / 2014 / Cilt: 44 - Sayı: 1

Clinical characteristics of patients with ıntermediate uveitis

İntermediyer üveitli hastaların klinik özellikleri

Pages
27–30
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Detailed clinical evaluation of such cases may reveal systemic diseases at the initial examinations or follow-up visits. (Turk J Ophthalmol 2014; 44: 27-30)

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: To analyze the clinical characteristics and findings in patients with intermediate uveitis.
📊
Key Findings & Data:Materials and Methods: The records of the 35 patients diagnosed as intermediate uveitis in our clinic between years 1996 and 2011 were reviewed retrospectively.
💡
Conclusion & Impact:Detailed clinical evaluation of such cases may reveal systemic diseases at the initial examinations or follow-up visits. (Turk J Ophthalmol 2014; 44: 27-30)
🔬Design:Review & Systematic Survey
📍Scope:2011 Verileri
⚙️Variables:Domain Parameters

Abstract

Objectives: To analyze the clinical characteristics and findings in patients with intermediate uveitis. Materials and Methods: The records of the 35 patients diagnosed as intermediate uveitis in our clinic between years 1996 and 2011 were reviewed retrospectively. Best-corrected visual acuity, intraocular pressure, slit lamp examination, dilated fundus examination, fundus fluorescein angiography, and systemic examination results of the patients were noted. Results: The mean follow-up time was 6.2 years (2-16 years). The mean age at diagnosis of intermediate uveitis was 32.4 years (8-68 years). 17.1% of patients were under 18 years old. 65.7% of patients were women, 34.2% were men, and both eyes were affected in 54.3% of patients. The most frequent findings were vitritis (100%), snowball opacities (97.1%), retinal vasculitis (65.7%), and snowbanking (45.7%). Concurrent iridocyclitis was determined in 71.4% of patients. Systemic association was found in 40.1% of patients, with disease being multiple sclerosis (22.9%), sarcoidosis (11.4%), tuberculosis (2.9%), or Lyme disease (2.9%). The most common complication that developed during the follow-up period included secondary glaucoma (22.9%), cataract formation (17.1%), and cystoid macular edema (17.1%). The visual acuity of 3 patients was less than 0.5 due to the optic atrophy, macular hole, and cystoid macular edema sequel, respectively. The mean final visual acuity of the remaining patients was 0.9±0.2. Conclusion: When the inflammation and complications are treated effectively in intermediate uveitis, the visual prognosis is fairly good. Detailed clinical evaluation of such cases may reveal systemic diseases at the initial examinations or follow-up visits. (Turk J Ophthalmol 2014; 44: 27-30)

Özet

Amaç: İntermediyer üveit tanılı hastaların klinik özelliklerinin ve bulgularının incelenmesi. Gereç ve Yöntem: 1996-2011 yılları arasında kliniğimizde intermediyer üveit tanısı konulan 35 hastanın kayıtları retrospektif olarak incelendi. Hastaların düzeltilmiş görme keskinliği, göz içi basınç ölçümü, biyomikroskopik ön segment muayene bulguları, dilate fundus muayenesi, fundus floresein anjiyografi bulguları ve sistemik muayene sonuçları kaydedildi. Bulgular: Ortalama takip süresi 6,2 yıldı (2-16 yıl). Ortalama tanı konulma yaşı 32,4 yıldı (8-68 yıl). Hastaların %17,1i 18 yaş altındaydı. Hastaların %65,7si kadın, %34,2si erkekti ve % 54,3ünün iki gözü de etkilenmişti. En sık görülen bulgular vitrit (%100), kartopu opasite (%97,1), retinal vaskülit (%65,7) ve kar birikintisi görünümüydü (%45,7). Hastaların % 71,4ünde iridosiklit eşlik etmekteydi. % 40,1 hastada eşlik eden sistemik hastalık tespit edildi, bu hastalıklar sırasıyla multiple skleroz (%22,9), sarkoidoz (%11,4), tüberküloz (%2,9) ve Lyme hastalığıydı (%2,9). Takip süresince gelişen en sık komplikasyonlar sekonder glokom (%22,9), katarakt (%17,1) ve kistoid maküler ödemdi (%17,1). Bir hastada optik atrofi, bir hastada maküler delik ve bir hastada kistoid maküler ödem sekeline bağlı görme keskinliği 0,5in altında kaldı. Geri kalan hastaların son görme keskinliği ortalama 0,9±0,2di. Sonuç: İntermediyer üveitte inflamasyon ve komplikasyonlar etkin tedavi edilirse görme prognozu oldukça iyidir. Detaylı klinik değerlendirmeyle olguların bir kısmında sistemik hastalık başlangıçta veya daha sonraki takiplerde saptanabilir. (Turk J Ophthalmol 2014; 44: 27-30)

🔖

Cite This Article

GÜR, S. G., AYDIN, Y. A. (2022). Clinical characteristics of patients with ıntermediate uveitis. Türk Oftalmoloji Dergisi, Cilt: 44 - Sayı: 1, 27–30. https://ajindex.com/articles/638055

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Bloch-Michel E, Nussenblatt B. International uveitis study group recommendations for the evaluation of intraocular inflammatory disease. Am J Ophthalmol. 1987;103:234-35.
  2. Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005;140:509-16.
  3. Zierhut M, Foster CS. Multiple sclerosis, sarcoidosis, and other diseases in patients with pars planitis. Dev Ophthalmol. 1992;23:41-7.
  4. Donaldson MJ, Pulido JS, Herman DC, Diehl N, Hodge D. Pars planitis: a 20-year study of incidence, clinical features, and outcomes. Am J Ophthalmol2007;144:812-7.
  5. De Boer J, Berendschot TT, Van der Does P, Rothova A. Long-term follow-up of intermediate uveitis in children. Am J Ophthalmol. 2006;141:616-21.
  6. Bonfioli AA, Damico FM, Curi AL, Orefice F. Intermediate uveitis. Semin Ophthalmol. 2005;20:147-54.
  7. Kazokoglu H, Onal S, Tugal-Tutkun İ, et al. Demographic and Clinical Features of Uveitis in Tertiary Centers in Turkey. Ophthalmic Epidemiology2008;15:285-93.
  8. Şengün A, Karadag R, Karakurt A, Saricaoglu MS, Abdik O, Hasiripi HCauses of Uveitis in a Referral Hospital in Ankara, Turkey. Ocular Immunol and Inflamm. 2005;13:45-50.
  9. Malla OK, Karki DB, Byanju RN, Shrestha S. Intermediate uveitis: a hospital based study. Kathmandu Univ Med J. 2004;2:354-59.
  10. Capone A, Aaberg TM. Intermediate uveitis. In: Albert DM, Jakobiec FA (eds) Principles and practice of ophthalmology, 1994; vol 1, chap 26. W.BSaunders, Philadelphia. BenEzra D, Cohen E, Maftzir G. Uveitis in children and adolescents. Br J Ophthalmol. 2005;89:444-8.
  11. Khairallah M, Hmidi K, Attia S, et al. Clinical characteristics of intermediate uveitis in Tunisian patients. Int Ophthalmol. 2010;30:531-7.
  12. Ortega-Lorrocea G, Arrllanes-Garcia L. Pars planitis: epidemiology and clinical outcome in a large community hospital in Mexico City. Int Ophthalmol. 1995;19:117-20.
  13. Park DW, Folk JC, Whitcup SM, et al. Phakic patients with cystoid macular edema, retinal periphlebitis, and vitreous inflammation. Arch Ophthalmol. 1998;116:1025-9.
  14. Arellanes-Gracia L, Navarro-Lopez L. Recillas-Gispert C. Pars planitis in the Mexican Mestizo population:ocular findings, treatment, and visual outcome. Ocul Inmunol Inflamm. 2003;11:53-60.
  15. Vidovic Valentincic N, Kraut A, Hawlina M, Stunf S, Rothova A. Intermediate uveitis: long-term course and visual outcome. Br J Ophthalmol. 2009;93:477- 8